|
MPST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.10029999997619E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.95900000000183E-05 |
| Normal-vs-Stage2 |
7.079700E-03 |
| Normal-vs-Stage3 |
1.176430E-04 |
| Normal-vs-Stage4 |
2.370100E-02 |
| Stage1-vs-Stage2 |
5.392600E-01 |
| Stage1-vs-Stage3 |
2.674600E-01 |
| Stage1-vs-Stage4 |
6.436000E-01 |
| Stage2-vs-Stage3 |
8.597000E-01 |
| Stage2-vs-Stage4 |
4.227000E-01 |
| Stage3-vs-Stage4 |
2.710600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.50040000002872E-07 |
| Normal-vs-AfricanAmerican |
3.843200E-01 |
| Normal-vs-Asian |
1.561350E-01 |
| Caucasian-vs-AfricanAmerican |
1.679020E-01 |
| Caucasian-vs-Asian |
5.175500E-02 |
| AfricanAmerican-vs-Asian |
9.764200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.51269999999682E-05 |
| Normal-vs-Female |
5.74799999999431E-05 |
| Male-vs-Female |
2.890000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.041600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.382180E-04 |
| Normal-vs-Age(61-80Yrs) |
3.718600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.348400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.906600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.091600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.040970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.211600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.376630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.798780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.330100E-02 |
| Classical-VS-Follicular |
4.820200E-01 |
| Classical-VS-Other |
2.329800E-01 |
| Classical-VS-Normal |
4.221500E-04 |
| Tall-VS-Follicular |
3.309800E-01 |
| Tall-VS-Other |
8.905800E-01 |
| Tall-VS-Normal |
1.578810E-03 |
| Follicular-VS-Other |
5.075800E-01 |
| Follicular-VS-Normal |
3.377700E-03 |
| Other-VS-Normal |
6.671600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.33199999996503E-06 |
| Normal-vs-N1 |
1.076300E-03 |
| N0-vs-N1 |
9.341600E-01 |
|
|
